PLAGL1 and central nervous system neoplasm: In keeping herewith, we show through ChIP-seq data that components of the Wnt-pathway such as FZD2 and FZD9 are direct targets of PLAGL1 and PLAGL2 and are overexpressed in the PLAGL1/2-amplified samples compared to the other CNS tumor types.